Clinical trials of the all-Italian anti Covid-19 vaccine has started. The vaccine is conceived by Takis of Castel Romano (Rome) and developed in collaboration with Rottapharm Biotech of Monza.
The first healthy volunteer of the 80 scheduled for phase 1 was vaccinated today in the San Gerardo hospital in Monza, one of the three Italian centers that, in collaboration with the University of Milan-Bicocca.
The clinical trials involve the National Cancer Institute Pascale Foundation of Naples and the National Institute of Infectious Diseases Lazzaro Spallanzani of Rome and the San Gerardo Hospital of Monza.
